Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update

Go back to Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update

BioNano Genomics, Inc. (BNGO) Reports Q4 EPS of $0.00

March 5, 2020 4:02 PM EST

BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q4 revenue of $2.8 million versus the consensus estimate of $4.42 million.

2019 was a tremendous year for the acceptance, recognition, and support our Saphyr system received from world-class institutions, and we expect to see that trend continue, said... More